| "Rescue" abciximab for complicated percutaneous transluminal coronary angioplasty. | |
| | |
MedLine Citation:
|
PMID: 9761094 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
We studied the in-hospital outcome of 138 consecutive patients who received abciximab as a "rescue" intervention for complicated coronary angioplasty in a high-risk clinical setting. "Rescue" treatment with abciximab was associated with clinical and angiographic success rates of 83% and 84%, respectively, whereas the risk of bleeding was higher in patients of low body weight. |
| | |
Authors:
|
E Garbarz; B Farah; A Vuillemenot; F André; M Angioï; J Machecourt; J P Bassand; J E Wolf; N Danchin; B Prendergast; B Iung; A Vahanian |
Related Documents
:
|
6222994 - Assessment of stenoses in coronary angioplasty. inter- and intraobserver variability. 2229784 - Results of coronary surgery after failed elective coronary angioplasty in patients with... 16889154 - Diphtheroid infection of a total knee arthroplasty following femoral percutaneous trans... 11113044 - Percutaneous coronary intervention in the current era compared with 1985-1986: the nati... 14613854 - Preservation of no production by statins in the treatment of heart failure. 6702554 - Effects of late coronary artery reperfusion after myocardial necrosis is complete. |
Publication Detail:
|
Type: Clinical Trial; Comparative Study; Journal Article; Multicenter Study |
Journal Detail:
|
Title: The American journal of cardiology Volume: 82 ISSN: 0002-9149 ISO Abbreviation: Am. J. Cardiol. Publication Date: 1998 Sep |
Date Detail:
|
Created Date: 1998-10-20 Completed Date: 1998-10-20 Revised Date: 2006-11-15 |
Medline Journal Info:
|
Nlm Unique ID: 0207277 Medline TA: Am J Cardiol Country: UNITED STATES |
Other Details:
|
Languages: eng Pagination: 800-3, A9 Citation Subset: AIM; IM |
Affiliation:
|
Cardiology Department, Tenon Hospital, Paris, France. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Angioplasty, Transluminal, Percutaneous Coronary
/
adverse effects* Antibodies, Monoclonal / therapeutic use* Coronary Angiography Coronary Thrombosis / drug therapy, etiology, radiography Follow-Up Studies Humans Immunoglobulin Fab Fragments / therapeutic use* Middle Aged Myocardial Ischemia / radiography, therapy* Platelet Aggregation Inhibitors / therapeutic use* Postoperative Complications / drug therapy*, etiology, radiography Prognosis Retrospective Studies Safety Thrombolytic Therapy Treatment Outcome |
| Chemical | |
Reg. No./Substance:
|
0/Antibodies, Monoclonal; 0/Immunoglobulin Fab Fragments; 0/Platelet Aggregation Inhibitors; 143653-53-6/abciximab |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Use of harmonic imaging without echocardiographic contrast to improve two-dimensional image quality.
Next Document: Clinical and angiographic outcome after stent placement for chronic coronary occlusion.